ADT trials for Prostate cancer

All ADT trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying ADT for Prostate cancer

• A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
  NCT04633252 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 110 Years · Sex: Male · 1 location
• A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
  NCT07450599 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 23 locations
• An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment
  NCT07538843 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
  NCT06235697 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 57 locations
• Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
  NCT06592924 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 395 locations
• National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
  NCT04086290 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
  NCT05406999 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)
  NCT07210086 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
  NCT05873192 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study ADT for Prostate cancer?

9 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.